These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 33669423)

  • 1. Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management.
    Singh A; Uzun G; Bakchoul T
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33669423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia.
    Althaus K; Faul C; Bakchoul T
    Hamostaseologie; 2021 Aug; 41(4):275-282. PubMed ID: 33348391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.
    Marini I; Bakchoul T
    Hamostaseologie; 2019 Aug; 39(3):227-237. PubMed ID: 30802916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
    Bakchoul T; Sachs UJ
    Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
    Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
    Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
    Nugent D; McMillan R; Nichol JL; Slichter SJ
    Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune attack on megakaryocytes in immune thrombocytopenia.
    Petito E; Gresele P
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102345. PubMed ID: 38525349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune thrombocytopenia (ITP): Pathophysiology update and diagnostic dilemmas.
    LeVine DN; Brooks MB
    Vet Clin Pathol; 2019 Oct; 48 Suppl 1():17-28. PubMed ID: 31538353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient in vitro megakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia.
    Parker RI; Siegel RS; Ratajczak MZ; Gewirtz AM
    J Pediatr Hematol Oncol; 1998; 20(3):196-201. PubMed ID: 9628429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of the human antibody-mediated platelet destruction in adult ITP patients by C-reactive protein.
    Pan JQ; Wang W; Wang ML; Li XY; Wang JH; Zhao WW; Tian YY; Dong XS; Jiang YF
    Int J Clin Exp Pathol; 2017; 10(10):10176-10185. PubMed ID: 31966351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
    Zhou H; Hou Y; Liu X; Qiu J; Feng Q; Wang Y; Zhang X; Min Y; Shao L; Liu X; Li G; Li L; Yang L; Xu S; Ni H; Peng J; Hou M
    Thromb Haemost; 2015 May; 113(5):1021-34. PubMed ID: 25566808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.
    Arnold DM; Nazi I; Toltl LJ; Ross C; Ivetic N; Smith JW; Liu Y; Kelton JG
    Eur J Haematol; 2015 Dec; 95(6):532-7. PubMed ID: 25684257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA IN ADULTS: UPDATE].
    Blickstein D
    Harefuah; 2019 Mar; 158(3):196-199. PubMed ID: 30916510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.
    Guo L; Kapur R; Aslam R; Hunt K; Hou Y; Zufferey A; Speck ER; Rondina MT; Lazarus AH; Ni H; Semple JW
    Scand J Immunol; 2018 Jul; 88(1):e12678. PubMed ID: 29855061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
    Gernsheimer T
    Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of immune thrombocytopenia.
    Neunert CE
    Hematology Am Soc Hematol Educ Program; 2013; 2013():276-82. PubMed ID: 24319191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell death in immune thrombocytopenia: novel insights and perspectives.
    von Gunten S; Wehrli M; Simon HU
    Semin Hematol; 2013 Jan; 50 Suppl 1():S109-15. PubMed ID: 23664507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.